Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Receives $500,000 Grant From Axelys, To Advance Development of ORTHO-M For #MeniscusRepair

SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Receives $500,000 Grant From Axelys, To Advance Development of ORTHO-M For #MeniscusRepair

posted on Jun 27, 2022 06:00PM

Share
New Message
Please login to post a reply